Nicotinic acetylcholine involvement in cogitive function in animals

Psychopharmacology

Volumn 138, Issue 3-4, 1998, Pages 217-230

  Levin, Edward D ^a   Simon, Barbara B ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Attention; Cognition; Memory; Nicotine

Indexed keywords

8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; ACETYLCHOLINE; CHOLINERGIC RECEPTOR; CORTICOSTERONE; DIZOCILPINE; DOPAMINE; EPIBATIDINE; GLUTAMIC ACID; HEXAMETHONIUM; MECAMYLAMINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NICOTINE; NICOTINIC AGENT; NICOTINIC RECEPTOR; NICOTINIC RECEPTOR BLOCKING AGENT; NORADRENALIN; RECEPTOR SUBTYPE; SCOPOLAMINE; SEROTONIN;

ALZHEIMER DISEASE; ATTENTION; CHOLINERGIC SYSTEM; COGNITION; FRONTAL CORTEX; HIPPOCAMPUS; HUMAN; LEARNING; MEMORY; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; REVIEW;

ACETYLCHOLINE; ANIMALS; ATTENTION; COGNITION; HUMANS; MEMORY; NICOTINIC AGONISTS; RECEPTORS, NEUROTRANSMITTER; RECEPTORS, NICOTINIC;

EID: 0031928549     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130050667     Document Type: Review

References (168)

1. Abdulla FA, Bradbury E, Calaminici MR, Lippiello PM, Wonnacott S, Gray JA, Sinden JD (1996) Relationship between up-regulation of nicotine binding sites in rat brain and delayed cognitive enhancement observed after chronic or acute nicotinic receptor stimulation. Psychopharmacology 124:323-331
2. Albuquerque EX, Alkondon M, Pereira EFR, Castro NG, Schrattenholz A, Barbosa CTF, BonfanteCabarcas R, Aracava Y, Eisenberg HM, Maelicke A (1997) Properties of neuronal nicotinic acetylcholine receptors: pharmacological characterization and modulation of synaptic function. J Pharmacol Exp Ther 280:1117-1136
3. Alder LE, Hoffer LJ, Griffith J, Waldo MC, Freedman R (1992) Normalization by nicotine of deficent auditory sensory gating in the relatives of schizophrenics. Biol Psychiatry 32:607-616
4. Alder LE, Hoffer LJ, Wiser A, Freedman R (1993) Cigarette smoking normalizes auditory physiology in schizophrenics. Am J Psychiatry 150:1856-1861
5. Alkonodon M, Albuquerque EX (1990) alpha-Cobratoxin blocks the nicotinic acetylcholine receptor in rat hippocampal neurons. Eur J Pharmacol 191:505-506
6. Alkondon M, Albuquerque EX (1993) Diversity of nicotinic acetylcholine receptors in rat hippocampal neurons: 1. Pharmacological and functional evidence for distinct structural subtypes. J Pharmacol Exp Ther 265:1455-1473
7. Andrews JS, Jansen JHM, Linders S, Princen A (1994) Effects of disrupting the cholinergic system on short-term spatial memory in rats. Psychopharmacology 115:485-494
8. Arendash GW, Sanberg PR, Sengstock GJ (1995a) Nicotine enhances the learning and memory of aged rats. Pharmacol Biochem Behav 52:517-523
9. Arendash GW, Sengstock GJ, Sanberg PR, Kem WR (1995b) Improved learning and memory in aged rats with chronic administration of the nicotinic receptor agonist GTS-21. Brain Res 674:252-259
10. Arneric SP, Sullivan JP, Williams M (1995) Neuronal nicotinic acetylchoine receptors: novel targets for central nervous system therapeutics. In: Bloom FE, Kupfer DE (eds) Psychopharmacology: the fourth generation of progress. Raven Press, New York, pp 95-110
11. Barbosa CTF, Alkondon M, Aracava Y, Maelicke A, Albuquerque EX (1996) Ligand-gated ion channels in acutely dissociated rat hippocampal neurons with long dendrites. Neurosci Lett 210:177-180
12. Barkley RA, Fischer M, Edelbrock CS, Smallish L (1990) The adolescent outcome of hyperactive children diagnosed by research criteria: I. An 8-year prospective follow-up study. J Am Acad Child Adolesc Psychiatry 29:546-557
13. 3 receptor antagonist, on cognition in rodents and primates. Pharmacol Biochem Behav 35:955-962
14. Baron JA (1986) Cigarette smoking and Parkinson's disease. Neurology 36:1490-1496
15. Baumann RJJ, McKean HD (1980) Cigarette smoking and Parkinson's disease: I. comparison of cases with matched neighbors. Neurology 30:839-843
16. Bencherif ML, Fowler KW, Arrington S, Reeves L, Caldwell WS, Lippiello PM (1996) RJR-2403: a nicotinic agonist with CNS selectivity I. In vitro characterization. J Pharmacol Exp Ther 279:1413-1421
17. Bickford PC, Wear KD (1995) Restoration of sensory gating of auditory evoked response by nicotine in fimbria-fornix lesioned rats. Brain Res 705:235-240
18. 1 agonist improves cognitive performance in rats. Pharmacol Biochem Behav 51:667-674
19. Brazell MP, Mitchell SN, Gray JA (1991) Effects of acute administration of nicotine on in vivo release of noradrenaline in the hippocampus of freely moving rats: a dose-response and antagonist study. Neuropharmacology 30:823-833
20. Brenner DE, Kukull WA, van Belle G, Bowen JD, McCormick WC, Teri L, Larson EB (1993) Relationship between cigarettee smoking and Alzheimer's disease in a population-based case-control study. Neurology 43:293-300
21. Briggs CAA, Brioni JG, Buccafusco JJ, Buckley MJ, Campbell JE, Decker MW, Donnelly-Roberts D, Elliott RL, Gopalakrishnan M, Holladay MW, Hui Y-H, Jackson WJ, Kim DJB, Marsh KC, O'Neill AL, Prendergast MA, Ry (1997) Functional characterization of the novel neuronal nicotinic acetylcholine receptor ligand GTS-21 in vitro and in vivo. Pharmacol Biochem Behav 57:231-241
22. Brioni JD, Arneric SP (1993) Nicotinic receptor agonists facilitate retention of avoidance training - participation of dopaminergic mechanisms. Behav Neural Biol 59:57-62
23. Brioni JD, Decker MW, Sullivan JP, Arneric SP (1997) The pharmacology of (-)-nicotine and novel cholinergic channel modulators. Adv Pharmacol 37:153-214
24. Broersen LM, Heinsbroek RPW, de Bruin JPC, Uylings HBM, Olivier B (1995) The role of the medial prefrontal cortex of rats in shrot-term memory functioning: further support for involvement of cholinergic, rather than dopaminergic mechanisms. Brain Res 674:221-229
25. Buccafusco JJ, Jackson WJ, Terry AV, Marsh KC, Decker MW, Arneric SP (1995) Improvement in performance of a delayed matching-to-sample task by monkeys following ABT-418: a novel cholinergic channel activator for memory enhancement. Psychopharmacology 120:256-266
26. Buccafusco JJ, Prendergast MA, Terry AV, Jackson WJ (1996) Cognitive effects of nicotinic cholinergic receptor agonists in nonhuman primates. Drug Dev Res 38:196-203
27. Bushnell PJ, Oshiro WM, Padnos BK (1997) Detection of visual signals by rats: effects of chlordiazepoxide and cholinergic and adrenergic drugs on sustained attention. Psychopharmacology 134:230-240
28. Carey GJC, Domeney AM, Gerrad PA, Jones DNC, Naylor RJ, Tyers MB (1992) Ondansetron and arecoline prevent scopolamine-induced cognitive deficits in the marmoset. Pharmacol Biochem Behav 42:75-83
29. 7 nicotinic receptor in rat cerebellar granule cell layer. NeuroReport 8:1431-1433
30. Castro NG, Albuquerque EX (1993) Brief-lifetime, fast-inactivating ion channels account for the alpha-bungarotoxin-sensitive nicotinic response in hippocampal neurons. Neurosci Lett 164: 137-140
31. Chambers RA, Moore J, McEvoy JP, Levin ED (1996) Cognitive effects of neonatal hippocampal lesions in a rat model of schizophrenia. Neuropsychopharmacology 15:587-594
32. Chavez-Noriega LE, Crona JH, Washburn MS, Urrutia A, Elliott KJ, Johnson EC (1997) Pharmacological characterization of recombinant human neuronal nicotinic acetylcholine receptors h alpha 2 beta 2, h alpha 2 beta 4, h alpha 3 beta 2, h alpha 3 beta 4, h alpha 4 beta 2, h alpha 4 beta 4 and h alpha 7 expressed in Xenopus oocytes. J Pharmacol Exp Ther 280:346-356
33. Clarke PBS (1989) Mapping of brain nicotinic receptors by autoradiographic techniques and the effect of experimental lesions. In: Norherg A, Fuxe K, Holmstedt B, Sundwall A (eds) Progress in brain research. Elsevier, New York, 65-71
34. Clarke PBS, Fibiger HC (1990) Reinforced alternation performance is impaired by muscarinic but not by nicotinic receptor blockade in rats. Behav Brain Res 36:203-207
35. Clarke PBS, Pert A (1985) Autoradiographic evidence for nicotine receptors on nigrostriatal and mesolimbic dopaminergic neurons. Brain Res 348:355-358
36. Clarke PBS, Pert CB, Pert A (1984) Autoradiographic distribution of nicotine receptors in rat brain. Brain Res 323:390-395
37. Conners CK, Levin ED, Sparrow E, Hinton S, Ernhardt D, Meck WH, Rose JE, March J (1996) Nicotine and attention in adult ADHD. Psychopharmacol Bull 32:67-73
38. Cregan E, Ordy JM, Palmer E, Blosser J, Wengenack T, Thomas G (1989) Spatial working memory enhancement by nicotine of aged Long-Evans rats in the T-maze. Soc Neurosci Abstr 15:731
39. Decker MW, Majchrzak MJ (1991) Nicotine-induced attenuation of spatial memory deficits in rats with septal lesions. Abstr Soc Neurosci 17:1235
40. Decker MW, Majchrzak MJ, Anderson DJ (1992) Effects of nicotine on spatial memory deficits in rats with septal lesions. Brain Res 572:281-285
41. Decker MW, Majchrzak MJ, Arneric SP (1993) Effects of lobeline, a nicotinic receptor agonist, on learning and memory Pharmacol Biochem Behav 45:571-576
42. Decker MW, Buckley MJ, Brioni JD (1994a) Differential effects of pretreatment with nicotine and lobeline on nicotine-induced chances in body temperature and locomotor activity in mice Drug Dev Res 31:52-58
43. Decker MW, Curzon P, Brioni JD, Arneric SP (1994b) Effects of ABT-418, a novel cholinergic channel ligand, on place learning in septal-lesioned rats. Eur J Pharmacol 261:217-222
44. Decker MW, Brioni JD, Bannon AW, Arneric SP (1995) Diversity of neuronal nicotinic acetylcholine receptors: lessons from behavior and implications for CNS therapeutics - minireview. Life Sci 56:545-570
45. delToro ED, Juiz JM, Smillie FI, Lindstrom J, Criado M (1997) Expression of alpha 7 neuronal nicotinic receptors during postnatal development of the rat cerebellum. Dev Brain Res 98:125-133
46. DiChiara B, Morelli M, Consolo S (1994) Modulatory functions of neurotransmitters in the striatum: ACh/dopamine/NMDA interactions. Trends Neurosci 17:228-233
47. Dunnett SB, Martel FL (1990) Proactive interference effects on short-term memory in rats: 1. Basic parameters and drug effects. Behav Neurosci 104:655-665
48. Elrod K, Buccafusco JJ (1988) Selective central nicotinic receptor blockade inhibits passive, but not active, avoidance learning in rats. Abstr Soc Neurosci 14:57
49. Elrod K, Buccafusco JJ, Jackson WJ (1988) Nicotine enhances delayed matching-to-sample performance by primates. Life Sci 43:277-287
50. Evenden JL, Turpin M, Oliver L, Jennings C (1993) Caffeine and nicotine improve visual tracking by rats - a comparison with amphetamine, cocaine and apomorphine. Psychopharmacology 110:169-176
51. Fadda F, Melis F, Stancampiano R (1996) Increased hippocampal acetylcholine release during a working memory task. Eur J Pharmacol 307:R1-R2
52. Faiman CP, DeErausquin GA, Baratti CM (1988) Vasopressin modulates the activity of nicotinic cholinergic mechanisms during memory retrieval in mice. Behav Neural Biol 50:112-119
53. Felix R, Levin ED (1997) Nicotinic antagonist administration into the ventral hippocampus and spatial working memory in rats. Neuroscience 81:1009-10017
54. Freedman R, Wetmore C, Stromberg I, Leonard S, Olson L (1993) alpha-Bungarotoxin binding to hippocampal interneurons - immunocytochemical characterization and effects on growth factor expression. J Neurosci 13:1965-1975
55. Freedman R, Hall M, Adler LE, Leonard S (1995) Evidence in postmortem brain tissue for decreased numbers of hippocampal nicotinic receptors in schizophrenia. Biol Psychiatry 38: 22-33
56. Granon S, Poucet B, Thinusblanc C, Changeux JP, Vidal C (1995) Nicotinic and muscarinic receptors in the rat prefrontal cortex: differential roles in working memory, response selection and effortful processing. Psychopharmacology 119:139-144
57. Gray JA, Mitchell SN, Joseph MH, Grigoryan GA, Bawe S, Hodges H (1994) Neurochemical mechanisms mediating the behavioral and cognitive effects of nicotine. Drug Dev Res 31:3-17
58. Gray R, Rajan AS, Radcliffe KA, Yakehiro M, Dani JA (1996) Hippocampal synaptic transmission enhanced by low concentrations of nicotine. Nature 383:713-716
59. Grigoryan G, Gray JA (1996) A single dose of nicotine proactively enhances the partial reinforcement extinction effect in the rat. Psychobiology 24:136-146
60. Grigoryan GA, Mitchell SN, Hodges H, Sinden JD, Gray JA (1994a) Are the cognitive-enhancing effects of nicotine in the rat with lesions ot the forebrain cholinergic projection system mediated by an interaction with the noradrenergic system? Pharmacol Biochem Behav 49:511-521
61. Grigoryan GA, Peters S, Gray JA, Hodges H (1994b) Interactions between the effects of propranolol and nicotine on radial maze performance of rats with lesions of the forebrain cholinergic projection system. Behav Pharmacol 5:265-280
62. Grigoryan G, Hodges H, Mitchell S, Sinden JD, Gray JA (1996) 6-OHDA lesions of the nucleus accumbens accentuate memory deficits in animals with lesions to the forebrain cholinergic projection system: effects of nicotine administration on learning and memory in the water maze. Neurobiol Learn Mem 65:135-153
63. Hamid S, Dawe GS, Gray JA, Stephenson JD (1997) Nicotine induces long-lasting potentiation in the dentate gyrus of nicotine-primed rats. Neurosci Res 29:81-85
64. Hodges H, Allen Y, Sinden J, Lantos PL, Gray JA (1991) Effects of cholinergic-rich neural grafts on radial maze performance of rats after excitotoxic lesions of the forebrain cholinergic projection system - II. Cholinergic drugs as probes to investigate lesion-induced deficits and transplant-induced functional recovery. Neuroscience 45:609-623
65. Hodges H, Sinden J, Turner JJ, Netto CA, Sowinski P, Gray JA (1992) Nicotine as a tool to characterise the role of the forebrain chloinergic projection system in cognition. In: Lippiello PM, Collins AC, Gray JA, Robinson JH (eds) The biology of nicotine: current research issues. Raven Press, New York
66. Hughes JR, Hatsukami DK, Mitchell JE, Dahlgren LA (1986) Prevelance of smoking among psychiatric outpatients. Am J Psychiatry 143:993-997
67. Ishikawa AM (1993) Effects of smoking in patients with early-onset Parkinson's disease. J Neurol Sci 117:28-32
68. Jackson WJ, Elrod K, Buccafusco JJ (1989) Delayed matching-to-sample in monkeys as a model for learning and memory deficits: role of brain nicotinic receptors. In: Meyer EM, Simpkins JW, Yamamoto J (eds) Novel approaches to the treatment of Alzheimer's disease. Plenum Press, New York, pp 39-52
69. Jarrard LE (1995) What does the hippocampus really do? Behav Brain Res 71:1-10
70. Jones GMM, Sahakian BJ, Levy R, Warburton DM, Gray JA (1992) Effects of acute subcutaneous nicotine on attention, information processing and short-term memory in Alzheimer's disease. Psychopharmacology 108:485-494
71. Joseph MH, Peters SL, Gray JA (1993) Nicotine blocks latent inhibition in rats: evidence for a critical role of increased functional activity of dopamine in the mesolimbic system at conditioning rather than pre-exposure. Psychopharmacology 110:187-192
72. 3H]γ-aminobutyric acid in the substantia nigra and in the globus pallidus of the rat. Brain Res 649:129-135
73. Kellar KJ, Wonnacott S (1990) Nicotinic cholinergic receptors in Alzheimer's disease. In: Wonnacott S, Russell MAH, Stolerman IP (eds) Nicotine psychopharmacology: molecular, cellular, and behavioral aspects. Oxford University Press, Oxford, pp 341-373
74. Kellar KJ, Whitehouse PJ, Martino-Barrows AM, Marcus K, Price DL (1987) Muscarinic and nicotinic cholinergic binding sites in Alzheimer's disease. Brain Res 436:62-68
75. Kellar JK, Giblin BA, Lumpkin MD (1989) Regulation of brain nicotinic cholinergic recognition sites and prolactin release by nicotine. In: Norberg A, Fuxe B, Sundwall A (eds) Progress in brain research. Elsevier New York, pp 209-216
76. Kim J, Levin E (1996) Nicotinic, muscarinic and dopaminergic actions in the ventral hippocampus and the nucleus accumbens: effects on spatial working memory in rats. Brain Res 725:231-240
77. Lee PN (1994) Smoking and Alzheimer's disease: a review of the epidemiological evidence. Neuroepidemiology 13:131-44
78. Levin ED (1992) Nicotinic systems and cognitive function. Psychopharmacology 108:417-431
79. Levin ED (1994) Nicotine effects and working memory performance. Rec Adv Tobacco Sci 20:49-66
80. Levin ED (1996) Nicotinic agonist and antagonist effects on memory. Drug Dev Res 38:188-195
81. Levin ED, Bettegowda C (1997) Nicotinic-NMDA interactions with working and reference memory. Soc Neurosci Abstr 23:216
82. 2 agonists: effects on working memory function. Drug Dev Res 31:32-37
83. Levin ED, Rose JE (1990) Anticholinergic sensitivity following chronic nicotine administration as measured by radial-arm maze performance in rats. Behav Pharmacol 1:511-520
84. Levin ED, Rose JE (1991) Nicotinic and muscarinic interactions and choice accuracy in the radial-arm maze. Brain Res Bull 27:125-128
85. 2 interactions with nicotinic and muscarinic systems. In: Levin ED, Decker MW, Butcher LL (eds) Neurotransmitter interactions and cognitive function. Birkhäuser, Boston, pp 144-158
86. Levin ED, Rose JE (1995) Acute and chronic nicotinic interactions with dopamine systems and working memory performance. In: Lajtha A, Abood L (eds) Functional diversity of interacting receptors. New York Academy of Sciences, New York, pp 218-221
87. Levin ED, Torry D (1995) Nicotine effects on memory performance. In: Clarke PBS, Quik M, Thurau K, Adlkofer F (eds) International symposium on nicotine: the effects of nicotine on biological systems II. Birkhäuser, Boston, pp 329-336
88. Levin ED, Torry D (1996) Acute and chronic nicotine effects on working memory in aged rats. Psychopharmacology 123:88-97
89. Levin ED, McGurk SR, South D, Butcher LL (1989) Effects of combined muscarinic and nicotinic blockade on choice accuracy in the radial-arm maze. Behav Neural Biol 51:270-277
90. Levin ED, Lee C, Rose JE, Reyes A, Ellison G, Jarvik M, Gritz E (1990a) Chronic nicotine and withdrawal effects on radial-arm maze performance in rats. Behav Neural Biol 53:269-276
91. Levin ED, McGurk SR, Rose JE, Butcher LL (1990b) Cholinergic-dopaminergic interactions in cognitive performance. Behav Neural Biol 54:271-299
92. Levin ED, Briggs SJ, Christopher NC, Rose JE (1992) Persistence of chronic nicotine-induced cognitive facilitation. Behav Neural Biol 58:152-158
93. Levin ED, Briggs SJ, Christopher NC, Rose JE (1993a) Chronic nicotinic stimulation and blockade effects on working memory. Behav Pharmacol 4:179-182
94. Levin ED, Christopher NC, Briggs SJ, Rose JE (1993b) Chronic nicotine reverses working memory deficits caused by lesions of the fimbria or medial basalocortical projection. Cognit Brain Res 1:137-143
95. Levin ED, Briggs SJ, Christopher NC, Auman JT (1994a) Working memory performance and cholinergic effects in the ventral tegmental area and substantia nigra. Brain Res 657:165-170
96. Levin ED, Christopher NC, Briggs SJ (1994b) Comparison of chronic nicotine and mecamylamine effects on working memory performance in the radial-arm maze and T-maze alternation. Soc Neurosci Abstr 20:151
97. Levin ED, Rose JE, Abood L (1995) Effects of nicotinic dimethylaminoethyl esters on working memory performance of rats in the radial-arm maze. Pharmacol Biochem Behav 51:369-373
98. 1 agonist and antagonist drugs. Psychopharmacology 127:25-30
99. Levin ED, Wilson W, Rose J, McEvoy J (1996b) Nicotine-haloperidol interactions and cognitive performance in schizophrenics. Neuropsychopharmacology 15:429-436
100. 2 dopamine effects in rats. Drug Dev Res 39:29-35
101. Levin ED, Conners CK, Sparrow E, Hinton S, Meck W, Rose JE, Ernhardt D, March J (1996d) Nicotine effects on adults with attention-deficit/hyperactivity disorder. Psychopharmacology 123:55-63
102. Levin ED, Toll K, Chang G, Christopher NC, Briggs SJ (1996e) Epibatidine, a potent nicotinic agonist: effects on learning and memory in the radial-arm maze. Med Chem Res 6:543-554
103. Levin ED, Kaplan S, Boardman A (1997a) Acute nicotine interactions with nicotinic and muscarinic antagonists: working and reference memory effects in the 16-arm radial maze. Behav Pharmacol 8:236-242
104. Levin ED, Christopher NC, Briggs SJ (1997b) Chronic nicotinic agonist and antagonist effects on T-maze alternation. Physiol Behav 61:863-866
105. Levin ED, Torry D, Christopher NC, Yu X, Einstein G, Schwartz-Bloom R (1997c) Is binding to nicotinic acetylcholine and dopamine receptors related to working memory in rats? Brain Res Bull 43:295-304
106. Levin ED, Conner CK, Silva D, Hinton SC, Meck WH, March J, Rose JE (1998) Nicotine skin patch effects on attention. Psychopharmacology (in press)
107. Lichtensteiger W, Hefti F, Felix D, Huwyler T, Melamed E, Schlumpf M (1982) Stimulation of nigrostriatal dopamine neurons by nicotine. Neuropharmacology 21:963
108. Lippiello PM, Bencherif M, Gray JA, Peters S, Grigoryan G, Hodges H, Collins AC (1996) RJR-2403: a nicotinic agonist with CNS selectivity II: in vivo characterization. J Pharmacol Exp Ther 279:1422-1429
109. Little JTB, Martin A, Hill JL, Tune LE, Mack C, Cantillon M, Molchan S, Murphy DL, Sunderland T (1995) Serotonergic modulation of anticholinergic effects on cognition and behavior in elderly humans. Psychopharmacology 120:280-288
110. Luntz-Leybman V, Bickford PC, Freedman R (1992) Cholinergic gating of response to auditory stimuli in rat hippocampus. Brain Res 587:130-136
111. Marks MJ, Stitzel JA, Romm E, Wehner JM, Collins AC (1986) Nicotinic binding sites in rat and mouse: comparison of acetylcholine, nicotine and α-bungarotoxin. Mol Pharmacol 30: 427-436
112. Marks MJ, Romm E, Campbell SM, Collins AC (1989) Variation of nicotinic binding sites among inbred strains. Pharmacol Biochem Behav 33:679-689
113. McEvoy J, Freudenreich O, Levin E, Rose J (1995) Haloperidol increases smoking in patients with schizophrenia. Psychopharmacology 119:124-126
114. McGehee DS, Heath MJS, Gelber S, Devay P, Role LW (1995) Nicotine enhancement of fast excitatory synaptic transmission in CNS by presynaptic receptors. Science 269:1692-1696
115. McGurk SR, Levin ED, Butcher LL (1989a) Nicotinie-dopaminergic relationships and radial-arm maze performance in rats. Behav Neural Biol 52:78-86
116. 2 dopaminergic drugs. Psychopharmacology 99:371-373
117. McGurk SR, Levin ED, Butcher LL (1992) Dopaminergic drugs reverse the impairment of radial-arm maze performance caused by lesions involving the cholinergic medial pathway. Neuroscience 50:129-135
118. Meyer EM, de Fiebre CM, Hunter BE, Simpkins CE, Frauworth N, de Fiebre NE (1994) Effects of anabaseine-related analogs on rat brain nicotinic receptor binding and on avoidance behaviors. Drug Dev Res 31:127-134
119. Mitchell SN, Brazell MP, Schugens MM, Gray JA (1990) Nicotine-induced catecholamine synthesis after lesions to the dorsal or ventral noradrenergic bundle. Eur J Pharmacol 179: 383-391
120. Miyata H, Hironaka N, Ando K (1991) Effects of cholinergic drugs on delayed discrimination disruption by AF64A in rats. Nippon Yakurigaku Zasshi 97:259-266
121. Moran PM (1993) Differential effects of scopolamine and mecamylamine on working and reference memory in the rat. Pharmacol Biochem Behav 45:533-538
122. Morens DM, Grandinetti A, Reed D (1995) Cigarette smoking and protections from Parkinson's disease: false association or etiologic clue? Neurology 45:1041-1051
123. 3 receptor antagonist, ondansetron. Psychopharmacolooy 118: 82-92
124. Naftchi NE, Maker H, Lapin E. Sleis J, Lajtha A, Leeman S (1988) Acute reduction of brain substance P induced by nicotine. Neurochem Res 13:305-309
125. Newhouse PA, Sunderland T, Tariot PN, Blumhardt CL, Weingartner H, Mellow A, Murphy DL (1988) Intravenous nicotine in Alzheimer's disease: a pilot study. Psychopharmacology 95: 171-175
126. Newhouse PA, Potter A, Levin ED (1997) Nicotinic system involvement in Alzheimer's and Parkinson's diseases: implications for therapeutics. Drugs Aging 11:1-23
127. Nordberg A (1994) Human nicotinic receptors - their role in aging and dementia. Neurochem Int 25:93-97
128. 3H-acetylcholine binding sites in the frontal cortex of Alzheimer brains. Neurosci Lett 72:115-119
129. Nordberg A, Alafuzoff I, Winblad B (1992) Nicotinic and muscarinic subtypes in the human brain: changes with aging and dementia. J Neurosci Res 31:103-111
130. Ohno M, Yamamoto T, Watanabe S (1993) Blockade of hippocampal nicotinic receptors impairs working memory but not reference memory in rats. Pharmacol Biochem Behav 45: 89-93
131. Pauly JR, Stitzel JA, Marks MJ, Collins AC (1989) An autoradioeraphic analysis of cholinergic receptors in mouse brain. Brain Res Bull 22:453-459
132. Pauly JR, Grun EU, Collins AC (1992) Glucocorticoid regulation of sensitivity to nicotine. In: Lippiello PM, Collins AC, Gray JA, Robinson JH (eds) The biology of nicotine: current research issues. Raven Press, New York, pp 121-137
133. Perry EK, Perry RH, Smith CJ (1987) Nicotinic receptor abnormalities in Alzheimer's and Parkinson's disease. J Neurol Neurosurg Psychiatry 50:806-809
134. Perry EKC, Dick DJ (1985) Cholinergic correlates of cognititve impairment in Parkinson's disease: comparisons with Alzheimer's disease. J Neurol Neurosurg Psychiatry 48:413-421
135. Picciotto MR, Zoll M, Lena C, Bessis A, Lallemand Y, Lenovere N, Vincent P, Pich EM, Brulet P, Changeux JP (1995) Abnormal avoidance learning in mice lacking functional high-affinity nicotine receptor in the brain. Nature 374:65-67
136. Pomerleau OF, Downey KK, Stelson FW, Pomerleau CS (1996) Cigarette smoking in adult patients diagnosed with attention deficit hyperactivity disorder. J Subst Abuse 7:373-378
137. Ridley RM, Murray TK, Johnson JA, Baker HF (1986) Learning impairment following lesion of basal nucleus of Meynert in the marmoset: modification by cholinergic drugs. Brain Res 376:108-116
138. Riekkinen PJS, Valjakka A, Miettinen R, Riekkinen P (1991) Pharmacological consequences of cholinergic plus serotonergic manipulations. Brain Res 552:23-26
139. Riekkinen M, Sirvio J, Riekkinen P (1993) Pharmacological consequences of nicotinergic plus serotonergic manipulations. Brain Res 622:139-146
140. Rochford J, Sen AP, Quirion R (1996) Effect of nicotine and nicotinic receptor agonists on latent inhibition in the rat. J Pharmacol Exp Ther 277:1267-1275
141. Sahakian B, Jones G, Levy R, Gray J, Warburton D (1989) The effects of nicotine on attention, information processing, and short-term memory in patients with dementia of Alzheimer type. Br J Psychiatry 154:797-800
142. Sargent PB (1993) The diversity of neuronal nicotinic acetylcholine receptors. Annu Rev Neurosci 16:403-443
143. Sasaki H, Yanai M, Meguro K, Sekizawa K, Ikarashi Y, Maruyuma Y, Yamamoto M, Matsuzaki Y, Takishima T (1991) Nicotine improves cognitive disturbance in rodents fed with a choline-deficient diet. Pharmacol Biochem Behav 38:921-925
144. Schoepfer R, Conroy WG, Whiting P, Gore M, Lindstrom J (1990) Brain alpha-bungarotoxin binding protein cDNAs and MAbs reveal subtypes of this branch of the ligand-gated ion channel gene superfamily. Neuron 5:35-48
145. Schwartz RD, Kellar KJ (1983) Nicotinic cholinergic binding sites in the brain: in vivo regulation. Science 220:214-216
146. 3H)acetylcholine on catecholamine and serotonin axons in brain. J Neurochein 42: 1495-1498
147. Segal M, Dudai Y, Amsterdam A (1978) Distribution of alpha-bungarotoxin-binding cholinergic nicotinic receptors in rat brain. Brain Res 148:105-119
148. Séguéla P, Wadiche J, Dineley-Miller K, Dani JA, Patrick JW (1993) Molecular cloning, functional properties and distribution of rat brain a7: a nicotinic cation channel highly permeable to calcium. J Neurosci 13:596-604
149. Sershen H, Lajtha A (1987) Behavioral and biochemical effects of nicotine in an MPTP-induced mouse model of Parkinson's disease. Pharmacol Biochem Behav 28:299-303
150. Sershen H, Toth E, Latjtha AI, Vizi ES (1995) Nicotine effects on presynaptic receptor interactions. Ann NY Acad Sci 757:238-244
151. Sershen H, Balla A, Lajtha A, Vizi ES (1997) Characterization of nicotinic receptors involved in the release of noradrenaline from the hippocampus. Neuroscience 77:121-139
152. Socci DJ, Sanberg PR, Arendash GW (1995) Nicotine enhances morris water maze performance of young and aged rats. Neurohiol Aging 16:857-860
153. Summers KL, Giacohini H (1995) Effects of local and repeated systemic administration of (-)nicotine on extracellular levels of acetylcholine, norepinephrine, dopamine, and serotonin in rat cortex. Neurocliem Res 20:753-759
154. Terry AVB, Decker MW (1997) Cholinergic channel activator, ABT-418, enhances delayed-response accuracy in rats. Drug Dev Res 40:304-312
155. Terry AV, Buccafusco JJ, Jackson WJ (1993) Scopolamine reversal of nicotine enhanced delayed Matching-to-sample performance in monkeys. Pharmacol Biochem Behav 45:925-929
156. Terry AV, Buccafusco JJ, Jackson WJ, Zagrodnik S, Evansmartin FF, Decker MW (1996) Effects of stimulation or blockade of central nicotinic-cholinergic receptors on performance of a novel version of the rat stimulus discrimination task. Psychopharmacology 123:172-181
157. Toth E, Sershen H, Hashim A, Vizi ES, Lajtha A (1992) Effect of nicotine on extracellular levels of neurotransmitters assessed by microdialysis in various brain regions: role of glutamic acid. Neurochein Res 17:265-271
158. Turchi J, Holley LA. Sarter M (1995) Effects of nicotinic acetylcholine receptor ligands on behavioral vigilance in rats. Psychopharmacology 118:195-205
159. Turner JJ, Hodges H, Sinden JD, Gray JA (1992) Comparison of radial maze performance of rats after ibotenate and quisqualate lesions of the forebrain cholinergic projection system: effects of pharmacological challenge and changes in training regime. Behav Pharmacol 3:359-373
160. Van Duijn CM, Clayton DG, Chandra V, Fratiglioni L, Graves AB, Heyman A, Jorm AF, Kokmen E, Kondo K, Mortimer JA et al. (1994) Interaction between genetic and environmental risk factors for Alzheimer's disease: a reanalysis of case-control studies. EURODEM Risk Factors Research Group. Genet Epidemiol 11:539-551
161. Van Duijn CM, Havekes LM, Van Broeckhoven C, de Knijff P, Hofman A (1995) Apolipoprotein E genotype and association between smoking and early onset Alzheimer's disease. BMJ 310:627-631
162. Vidal C, Changeux JP (1996) Neuronal nicotinic acetylcholine receptors in the brain. News Physiol Sci 11:202-208
163. Wada H, Wada K, Boulter J, Deneris E, Heinemann S (1989) Distribution of α2, α3, α4 and β2 neuronal nicotinic subunit mRNAs in the central nervous system: a hybridization histochemical study in rat. J Comp Neurol 284:314-335
164. While-house PJ, Hedreen JC, While CL (1983) Basal forebrain neurons in dementia of Parkinson's disease. Ann Neurol 13: 243-248
165. Wilson AL, Langley LK, Monley J, Bauer T, Rottunda S, Metalls E, Kovera C, Mccarten JR (1995) Nicotine patches in Alzheimer's disease: pilot study on learning, memory, and safety. Pharmacol Biochem Behav 51:509-514
166. Wonnacott S, Soliakov L, Wilkie G, Redfern P, Marshall D (1996) Presynaptic nicotinic acetyleholine receptors in the brain. Drug Dev Res 38:149-159
167. Woodruff-Pak DS, Li YT, Kem WR (1994) A nicotinic agonist (GTS-21), eyeblink classical conditioning, and nicotinic receptor binding in rabbit brain. Brain Res 645:309-317
168. Zarrindast MR, Sadegh M, Sbafagbi B (1996) Effects of nicotine on memory retrieval in mice. Eur J Pharmacol 295:1-6